Medical Health & Life Science Research News

New report: Improving health care infrastructure and technological advancements drives the global biological safety testing market

The lack of diverse products also hinders the players to device effective marketing strategies to gain ground over their competitors.

- Advertising -

A recent market intelligent study by Transparency Market Research has detected that the competition in global biological safety testing market is moderate, a pattern that will continue in the near future too, on the account of similarity of the products offered by the different vendors. 

In this scenario, the TMR report suggests that the China-based vendors will have an advantage over the competitors in the global biological safety testing market, as the country offers low cost skilled labor and a robust manufacturing infrastructure. According to the analyst of the report, lenient government regulations is another key aspect that is keeping China at the forefront of focus by the leading vendors for their business.

- Advertising -

As per the estimations of the TMR report, the global market for biological safety testing will be worth US$3.08 bn by the end of 2024, expanding robustly at a CAGR of 10.0% during the forecast period of 2016 to 2024, significantly up from its evaluated worth of US$1.31 bn in 2015. The report rates Thermo Fisher Scientific, Inc., Merck KGaA, Charles River Laboratories International, Inc., Lonza Group, and Wuxi Pharma Tech (Cayman), Inc.

as the top five companies currently operating in the global biological safety testing market, accounting for 71% of the global shares in 2015, which makes it a highly consolidated environment. In the near future, mergers and acquisition of promising new entrants is expected to help these market leaders to gain ground over their competitors.

Reagents and Kits Segment Projected for Healthy Growth Rate

Product-wise, the report segments the global biological safety testing market into instruments and reagent and kits. In 2015, the instruments segment, which is further sub-segmented into biological safety cabinet of class I, II, and III, autoclaves, and laboratory centrifuges, accounted for 29.2% of the demand.

However, this segment is anticipated for a moderate growth rate, while reagents and kits segment will prosper quickly, gaining traction from the growing popularity of new technologies and the advent of new instruments currently developed by various companies such as Charles River Laboratories International, Inc. and Thermo Fisher Scientific.

Application-wise, the TMR report categorizes the global biological safety testing market into vaccines and therapeutics, tissue and tissue products, blood and blood products, gene therapy, term cell products, and cellular therapy, and identifies vaccines and therapeutics segment as most profitable, accounting for little less than a third of the global demand.

Asia Pacific Emerging as Lucrative Region

In 2015, North America was the most profitable region, serving 42.2% out of the global demand, followed by Europe. However, the presence of emerging economies such as India and China is expected to turn Asia Pacific as a highly lucrative region towards the end of the forecast period.

Both these countries have a flourishing pharmaceutical and biotechnology industries, and various companies are outsourcing their research and development activities to this region.

Exclusive Sample of this Report @ www.transparencymarketresearch.com…&rep_id=18578

Advancements in Biotechnology and Life Science Driving Demand

Growth of the pharmaceutical and biotechnology industries as a result of government support, increased investment in research and developments in the field of life sciences, growing number of drug launches, and the prevalence of several chronic diseases are some of the key factors driving the demand in the global biological safety testing market. On the other hand, the lack of skilled professionals is hindering the market from attaining its full potential.

Nevertheless, emerging economies and rapidly increasing pharmaceutical outsourcing will open new opportunities for the vendors operating in this market.

The information presented in this review is based on a Transparency Market Research report, titled, “Biological Safety Testing Market (Product Type - Instruments and Reagents & Kits; Test - Endotoxin Tests, Sterility Test, Cell Line Authentication and Characterization Tests, Bioburden Tests, Residual Host Contaminant Detection Tests, Adventitious Agent Detection Tests, Toxicity Tests, and Stability Tests; Application - Vaccines & Therapeutics, Blood & Blood Products, Tissue & Tissue Products, Stem Cell Products, Gene Therapy, and Cellular Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

News From

Transparency Market Research - In-depth AnalysisTransparency Market Research
Category: Market Research Publishers and RetailersCompany profile: TMR provides a range of marketing and business research solutions designed for your specific needs. From off-the-shelf syndicated business And market research to made-to-order custom research, we serve our clients to fulfill their immediate as well as ongoing research requirements.      We specialize in the following areas:   Syndicated Research Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverage ...